Inhibition of adenovirus-mediated p27kip1 gene on growth of esophageal carcinoma cell strain

World Journal of Gastroenterology

Volumn 9, Issue 11, 2003, Pages 2404-2408

  Wu, Qing Ming ^a,b   Yu, Jie Ping ^a   Tong, Qiang ^b   Wang, Xiao Hu ^b   Xie, Guo Jian ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LEUCINE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DIVISION; CELL STRAIN; CONTROLLED STUDY; DNA REPLICATION; DRUG EFFECT; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0344874662     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i11.2404     Document Type: Article

References (32)

1. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22
2. Harada K, Supriatno Yoshida H, Sato M. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma. Anticancer Res 2002; 22: 2985-2989
3. Chen AJ, Meng QH, Long B, Yang GL. Relationship between p27 expression and prognosis of colorectal carcinoma. Ai Zheng 2002; 21: 1075-1077
4. Myung N, Kim MR, Chung IP, Kim H, Jang JJ. Loss of p16 and p27 is associated with progression of human gastric cancer. Cancer Lett 2000; 153: 129-136
5. Lacoste-Collin L, Gomez-Brouchet A, Escourrou G, Delisle MB, Levade T, Uro-Coste E. Expression of p27(Kip1) in bladder cancers: Immunohistochemical study and prognostic value in a series of 95 cases. Cancer Lett 2002; 186: 115-120
6. Schwerer MJ, Sailer A, Kraft K, Maier H. Cell proliferation and p27Kip1 expression in endophytic schneiderian papillomas. Laryngoscope 2002; 112: 852-857
7. Cesinaro AM, Migaldi M, Corrado S, Maiorana A. Expression of p27kip1 in basal cell carcinomas and trichoepitheliomas. Am J Dermatopathol 2002; 24: 313-318
8. Zhang X, Liu S, Liang C, Yang H. Adenovirus-mediated Rb gene transfect for head and neck cancer. Huaxi Yike Daxue Xuebao 2001; 32: 194-195
9. Roth JA, Cristiano RJ. Gene therapy for cancer: What have we done and where are we going? J Nat Cancer Inst 1997; 89: 21-39
10. Matsubara H, Maeda T, Gunji Y, Koide Y, Asano T, Ochiai T, Sakiyama S, Tagawa M. Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells. Int J Oncol 2001; 18: 825-829
11. Shimada H, Shimizu T, Ochiai T, Liu TL, Sashiyama H, Nakamura A, Matsubara H, Gunji Y, Kobayashi S, Tagawa M, Sakiyama S, Hiwasa T. Preclinical study of adenoviral p53 gene therapy for esophageal cancer. Surg Today 2001; 31: 597-604
12. Fujii T, Tanaka Y, Tanaka T, Matono S, Sueyoshi S, Fujita H, Shirouzu K, Kato, S, Yamana H. Experimental gene therapy using p21/WAF1 gene is esophageal squamous cell carcinoma-adenovirus infection and gene gun technology. Gan To Kagaku Ryoho 2001; 28: 1651-1654
13. Wu MY, Chen MH, Liang YR, Meng GZ, Yang HX, Zhuang CX. Experimental and clinicopathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma. World J Gastroenterol 2001; 7: 490-495
14. Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res 2001; 61: 1578-1584
15. Gu ZP, Wang YJ, Li JG, Zhou YA. VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma. World J Gastroenterol 2002; 8: 44-48
16. Yang HL, Dong YB, Elliott MJ, Liu TJ, McMasters KM. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Clin Cancer Res 2000; 6: 1579-1589
17. Guo WZ, Ran YL, Liu J, Yu L, Sun LX, Yang ZH. Enhancement by hypoxia of antisense VEGF(165) gene expression in esophageal cancer cells. Shengwu Huaxue Yushengwu Wuli Xuebao (Shanghai) 2002; 34: 625-629
18. Tsunoo H, Komura S, Ohishi N, Yajima H, Akiyama S, Kasai Y, Ito K, Nakao A, Yagi K. Effect of transfection with human interferon-beta gene entrapped in cationic multilamellar liposomes in combination with 5-fluorouracil on the growth of human esophageal cancer cells in vitro. Anticancer Res 2002; 22: 1537-1543
19. Shimada H, Matsubara H, Ochiai T. Gene therapy for esophageal cancer. Nippon Geka Gakkai Zasshi 2002; 103: 371-375
20. Koguchi K, Nakatsuji Y, Nakayama K, Sakoda S. Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27 (Kip1). Glia 2002; 37: 93-104
21. Katner AL, Gootam P, Hoang QB, Gnarra JR, Rayford W. A recombinant adenovirus expressing p27(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells. J Urol 2002; 168: 766-773
22. Patel SD, Tran AC, Ge Y, Moskalenko M, Tsui L, Banik G, Tom W, Scott M, Chen L, Van Roey M, Rivkin M, Mendez M, Gyuris J, McArthur JG. The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene. Mol Ther 2000; 2: 161-169
23. Craig C, Wersto R, Kim M, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K, Seth P. A recombinant adenovirus expression p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 1997; 14: 2283-2289
24. Matsuo T, Seth P, Thiele CJ. Increased expression of p27Kip1 arrests neuroblastoma cell growth. Med Pediatr Oncol 2001; 36: 97-99
25. Katner AL, Hoang QB, Gootam P, Jaruga E, Ma Q, Gnarra J, Rayford W. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expression p27(Kip1). Prostate 2002; 53: 77-87
26. Turturro F, Seth P. Prolonged adenovirus-mediated expression of p27(kip1) unveils unexpected effects of this protein on the phenotype of SUDHL-1 cells derived from t(2;5)-anaplastic large cell lymphoma. Leuk Res 2003; 27: 329-335
27. Zhang WW. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 1999; 6: 113-138
28. Tseng JF, Farnebo FA, Kisker O, Becker CM, Kuo CJ, Folkman J, Mulligan RC. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. Surgery 2002; 132: 857-865
29. Yasunaga M, Tabira Y, Nakano K, Iida S, Ichimaru N, Nagamoto N, Sakaguchi T. Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma. Ann Thorac Surg 2000;70: 1634-1640
30. Shamma A, Doki Y, Tsujinaka T, Shiozaki H, Inoue M, Yano M, Kawanishi K, Monden M. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 2000; 58: 152-158
31. Shibata H, Matsubara O, Wakiyama H, Tanaka S. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus. Pathol Res Pract 2001; 197: 157-164
32. Taniere P, Martel-Planche G, Saurin JC, Lombard-Bohas C, Berger F, Scoazec JY, Hainaut P. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 2001; 85: 721-726